Fiumara P - Search Results

1

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.

Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F. Younes A, et al. Among authors: fiumara p. Clin Cancer Res. 2004 Aug 15;10(16):5432-8. doi: 10.1158/1078-0432.CCR-04-0540. Clin Cancer Res. 2004. PMID: 15328181 Clinical Trial.

2

A pilot study of rituximab in patients with recurrent, classic Hodgkin disease.

Younes A, Romaguera J, Hagemeister F, McLaughlin P, Rodriguez MA, Fiumara P, Goy A, Jeha S, Manning JT Jr, Jones D, Abruzzo LV, Medeiros LJ. Younes A, et al. Among authors: fiumara p. Cancer. 2003 Jul 15;98(2):310-4. doi: 10.1002/cncr.11511. Cancer. 2003. PMID: 12872350 Free article. Clinical Trial.

3

Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers.

Fiumara P, Cabanillas F, Younes A. Fiumara P, et al. Blood. 2001 Nov 1;98(9):2877-8. doi: 10.1182/blood.v98.9.2877. Blood. 2001. PMID: 11697338 Free article. No abstract available.

4

CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.

Fiumara P, Younes A. Fiumara P, et al. Br J Haematol. 2001 May;113(2):265-74. doi: 10.1046/j.1365-2141.2001.02593.x. Br J Haematol. 2001. PMID: 11380390 Free article. Review. No abstract available.

5

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB, Younes A. Fiumara P, et al. Blood. 2001 Nov 1;98(9):2784-90. doi: 10.1182/blood.v98.9.2784. Blood. 2001. PMID: 11675352 Free article.

6

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A. Zheng B, et al. Among authors: fiumara p. Blood. 2003 Aug 1;102(3):1019-27. doi: 10.1182/blood-2002-11-3507. Epub 2003 Apr 10. Blood. 2003. PMID: 12689928 Free article.

7

Multidrug resistance mechanisms in chronic lymphocytic leukaemia.

Consoli U, Santonocito A, Stagno F, Fiumara P, Privitera A, Parisi G, Giustolisi GM, Pavone B, Palumbo GA, Di Raimondo F, Milone G, Guglielmo P, Giustolisi R. Consoli U, et al. Among authors: fiumara p. Br J Haematol. 2002 Mar;116(4):774-80. doi: 10.1046/j.0007-1048.2002.03344.x. Br J Haematol. 2002. PMID: 11886380 Free article.

8

Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor.

Stagno F, Guglielmo P, Consoli U, Fiumara P, Russo M, Giustolisi R. Stagno F, et al. Among authors: fiumara p. Blood. 1999 Aug 15;94(4):1479-80. Blood. 1999. PMID: 10484634 Free article. No abstract available.

9

All-trans-retinoic-acid- and growth-factor- mediated induction of alkaline phosphatase activity in freshly isolated chronic myeloid leukemia cells.

Stagno F, Guglielmo P, Consoli U, Fiumara P, Longo GS, Giustolisi R. Stagno F, et al. Among authors: fiumara p. Acta Haematol. 1999;102(2):61-5. doi: 10.1159/000040971. Acta Haematol. 1999. PMID: 10529507

10

[Management of multiple myeloma].

Di Raimondo F, Pennisi A, Bari A, Fiumara P, Palumbo GA. Di Raimondo F, et al. Among authors: fiumara p. G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S46-52. G Ital Nefrol. 2005. PMID: 16419006 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page